• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.作者更正:用于H3K27M弥漫性中线胶质瘤的静脉内和颅内GD2嵌合抗原受体T细胞
Nature. 2024 Dec;636(8043):E6. doi: 10.1038/s41586-024-08452-3.
2
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.用于 H3K27M 突变型弥漫性中线脑胶质瘤的 GD2-CAR T 细胞疗法。
Nature. 2022 Mar;603(7903):934-941. doi: 10.1038/s41586-022-04489-4. Epub 2022 Feb 7.
3
Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.用于H3K27M弥漫性中线胶质瘤的静脉内和颅内GD2嵌合抗原受体T细胞
Nature. 2025 Jan;637(8046):708-715. doi: 10.1038/s41586-024-08171-9. Epub 2024 Nov 13.
4
Sequential intravenous and intracerebroventricular GD2-CAR T-cell therapy for H3K27M-mutated diffuse midline gliomas.序贯静脉内和脑室内GD2嵌合抗原受体T细胞疗法治疗H3K27M突变型弥漫性中线胶质瘤
medRxiv. 2024 Jun 27:2024.06.25.24309146. doi: 10.1101/2024.06.25.24309146.
5
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.双 IGF1R/IR 抑制剂联合 GD2-CAR T 细胞在弥漫性中线胶质瘤 H3K27M 突变体中显示出强大的抗肿瘤活性。
Neuro Oncol. 2022 Jul 1;24(7):1150-1163. doi: 10.1093/neuonc/noab300.
6
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M diffuse midline gliomas.抗 GD2 CAR T 细胞在 H3-K27M 弥漫性中线脑胶质瘤中的强大抗肿瘤疗效。
Nat Med. 2018 May;24(5):572-579. doi: 10.1038/s41591-018-0006-x. Epub 2018 Apr 16.
7
Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma.利用神经节苷脂治疗尤因肉瘤和H3K27M突变型弥漫性中线胶质瘤。
Cancers (Basel). 2021 Jan 29;13(3):520. doi: 10.3390/cancers13030520.
8
Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models.靶向GD2的瞬时mRNA CAR T细胞对弥漫性中线胶质瘤和高级别胶质瘤模型具有剂量调整后的疗效。
Neuro Oncol. 2025 May 24. doi: 10.1093/neuonc/noaf115.
9
GD2-CAR T Cell Therapy for H3K27M Diffuse Intrinsic Pontine Glioma: A Phase I Clinical Trial and Mechanistic Insights.用于H3K27M弥漫性固有脑桥胶质瘤的GD2嵌合抗原受体T细胞疗法:一项I期临床试验及机制研究
Immunology. 2026 Feb;177(2):247-251. doi: 10.1111/imm.70019. Epub 2025 Jul 19.
10
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.弥漫性中线胶质瘤 H3K27M 突变型的预后标志物的鉴定。
Brain Pathol. 2020 Jan;30(1):179-190. doi: 10.1111/bpa.12768. Epub 2019 Aug 14.

引用本文的文献

1
Exploring the tumor microenvironment in diffuse intrinsic pontine glioma: immunological insights and therapeutic challenges.探索弥漫性脑桥内在型胶质瘤的肿瘤微环境:免疫学见解与治疗挑战
J Immunother Cancer. 2025 Jun 12;13(6):e012009. doi: 10.1136/jitc-2025-012009.

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.

作者信息

Monje Michelle, Mahdi Jasia, Majzner Robbie, Yeom Kristen W, Schultz Liora M, Richards Rebecca M, Barsan Valentin, Song Kun-Wei, Kamens Jen, Baggott Christina, Kunicki Michael, Rietberg Skyler P, Lim Alexandria Sung, Reschke Agnes, Mavroukakis Sharon, Egeler Emily, Moon Jennifer, Patel Shabnum, Chinnasamy Harshini, Erickson Courtney, Jacobs Ashley, Duh Allison K, Tunuguntla Ramya, Klysz Dorota Danuta, Fowler Carley, Green Sean, Beebe Barbara, Carr Casey, Fujimoto Michelle, Brown Annie Kathleen, Petersen Ann-Louise G, McIntyre Catherine, Siddiqui Aman, Lepori-Bui Nadia, Villar Katlin, Pham Kymhuynh, Bove Rachel, Musa Eric, Reynolds Warren D, Kuo Adam, Prabhu Snehit, Rasmussen Lindsey, Cornell Timothy T, Partap Sonia, Fisher Paul G, Campen Cynthia J, Grant Gerald, Prolo Laura, Ye Xiaobu, Sahaf Bita, Davis Kara L, Feldman Steven A, Ramakrishna Sneha, Mackall Crystal

机构信息

Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.

Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.

出版信息

Nature. 2024 Dec;636(8043):E6. doi: 10.1038/s41586-024-08452-3.

DOI:10.1038/s41586-024-08452-3
PMID:39613972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11655351/
Abstract
摘要